Herborium Group Reports Record 6 Month Revenues

FORT LEE, N.J., June 27, 2012 /PRNewswire/ -- Herborium Group, Inc., ( HBRM) www.herborium.com, a Botanical Therapeutics® Company announces today that its revenues from AcnEase®, all botanical, proprietary acne treatment, grew over 25 percent in  the first  six months  of 2012  in comparison to the same period of 2011. Gross Profit increased 4.5%  .

"We are truly pleased by the accelerated  sales  of AcnEase that we  have achieved during  the first six months of this  year.  Considering a difficult economic climate, our growth is even more impressive and proves that Herborium's marketing strategy is working. Social Media Campaign that we deployed  last fall increased  on-line traffic  for AcnEase®  87%, and number of AcnEase  Facebook followers  by 49%.  There is over 60 million people with acne in the USA alone. We have also received a number of distributorship inquiries to sell AcnEase that we are presently working to complete. We expect that a success of our  digital marketing will result in further growth of revenues and increase of our market share leading to a record year for Herborium. Expected launch of Herborium sexual health and energy products in the Fall should add to this growth," commented Dr. Agnes  P. Olszewski, Chairman and CEO of Herborium.

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company sales its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com.

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: Investorsrelations@herborium.com